Jeffrey Todd Cislini's Stock Transactions in Revolution Medicines Inc

Jeffrey Todd Cislini, an officer at Revolution Medicines Inc, has filed a Form 144 notice detailing his stock transactions. On October 17, 2025, Cislini exercised stock options to acquire 12,000 shares of common stock. Additionally, he sold 1,799 shares on September 24, 2025, for $79,623.74 and 1,869 shares on September 16, 2025, for $85,646.74. The transactions were conducted under a Rule 10b5-1 trading plan, which allows company insiders to sell shares at predetermined times to avoid accusations of insider trading. The aggregate market value of the securities to be sold is $596,160.00. The transactions were facilitated by Morgan Stanley Smith Barney LLC Executive Financial Services.